Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-03

Clinical Trial Update: Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating selinexor in combination with standard chemoradiation as neoadjuvant treatment for locally advanced rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selinexor (selinexor)

Snippet

Sponsor: Sheba Medical Center | Conditions: Rectal Neoplasms | Phase 1 | Status: UNKNOWN